Issue 9 - Exploring Microsoft D365 customers globally
Darren Locking
Providing D365 customers and partners a competitive advantage rather than a candidate.
This week I thought I would explore one particular industry and decided upon the Biotechnology sector.
The biotechnology industry is flourishing. From protecting the planet to battling Covid-19, biotech is big business.
Estimates suggest that by 2028 the global biotech business will be worth $2.44 trillion.
What's more, biotech companies are investing heavily in technology and systems. D365 seems to be a favoured option.
Here are some biotech companies already using D365 as a transformative cog:
Organogenesis
Headquartered:?US
Product:?D365 F&O and D365 CE
Organogenesis is a pioneering company in the field of regenerative medicine, leading the way in the development and manufacturing of advanced tissue engineering solutions. With a deep-rooted commitment to transforming healthcare, Organogenesis specializes in creating innovative therapies that harness the body's natural healing abilities.
The team at Organogenesis comprises skilled researchers and clinicians who work tirelessly to create state-of-the-art products that address critical medical needs, including wound care, orthopedics, and plastic surgery. Organogenesis is dedicated to improving patients' lives by providing safe and effective treatments that promote tissue regeneration and healing.
As a trusted leader in regenerative medicine, Organogenesis sets the standard for quality, safety, and innovation. The company is proud to contribute to the advancement of healthcare and looks forward to a future where its transformative therapies continue to enhance the well-being of individuals worldwide.
Oxford Nanopore Technologies
Headquartered:?UK
Product:?D365 F&O
Oxford Nanopore Technologies is a trailblazing company in the field of genomics and DNA sequencing, renowned for its cutting-edge technologies and innovative solutions. With a steadfast commitment to advancing the understanding of genetics, Oxford Nanopore Technologies specializes in the development and commercialization of nanopore-based sequencing platforms.
The dedicated team at Oxford Nanopore Technologies, comprised of brilliant scientists and engineers, tirelessly pushes the boundaries of scientific discovery. Their work spans applications in genomics, clinical diagnostics, and more, empowering researchers and clinicians worldwide with unprecedented insights into DNA and RNA.
As a globally recognized leader in the genomics industry, Oxford Nanopore Technologies sets the standard for precision, accuracy, and scalability in sequencing technology. The company is proud to be at the forefront of genomics research, and it envisions a future where its revolutionary technologies continue to revolutionize the field.
领英推荐
Scienion
Headquartered: Germany
Product:?D365 F&O
Scienion is a pioneering company specializing in precision liquid handling and dispensing technologies, celebrated for its innovative solutions across various scientific disciplines. With an unwavering commitment to advancing scientific research, Scienion excels in the development and manufacturing of cutting-edge liquid handling platforms.
At Scienion, a dedicated team of experts, including scientists and engineers, tirelessly works to create state-of-the-art systems that facilitate high-throughput applications in genomics, proteomics, diagnostics, and beyond. The company's technologies empower researchers and laboratories worldwide to accelerate their experiments, ultimately driving advancements in healthcare and life sciences.
As a globally recognized leader in liquid handling technology, Scienion sets the benchmark for accuracy, precision, and efficiency.
ADC Therapeutics
Headquartered:?Switzerland
Product:?D365 F&O
ADC Therapeutics is a leading biotechnology company with a strong focus on developing innovative antibody-drug conjugate (ADC) therapies for the treatment of cancer. Committed to advancing oncology treatment, ADC Therapeutics specializes in creating next-generation ADCs that precisely target and deliver potent cytotoxic agents to cancer cells while sparing healthy tissue.
At ADC Therapeutics, a dedicated team of scientists, clinicians, and researchers works tirelessly to develop breakthrough therapies that address unmet medical needs in various cancer types. The company's novel ADC platforms offer promising options for patients, aiming to improve outcomes and minimize side effects.
As a trusted leader in ADC development, ADC Therapeutics stands at the forefront of cancer research and treatment. The company is dedicated to making a significant impact on the lives of cancer patients and continues to drive innovation in the field of targeted cancer therapies.
Biolab Sciences
Headquartered:?US
Product:?D365 BC
BioLab Sciences is a cutting-edge biotechnology company at the forefront of scientific innovation. Founded with a passion for advancing healthcare, they specialize in research, development, and manufacturing of groundbreaking medical solutions. A dedicated team of scientists and engineers work tirelessly to create state-of-the-art products that improve lives worldwide.
With a commitment to sustainability and ethical practices, BioLab Sciences is recognized for its environmentally responsible approach to biotechnology. Their portfolio spans regenerative medicine, pharmaceuticals, and diagnostic tools, all aimed at enhancing human well-being.
I hope you enjoy reading and as always, have a fantastic week ahead.
This was very interesting - crazy to see how this industry has grown!